90 related articles for article (PubMed ID: 17973260)
1. Family history of breast or ovarian cancer modifies the risk of secondary leukemia after breast cancer: results from a population-based study.
Verkooijen HM; Fioretta G; Rapiti E; Vlastos G; Neyroud-Caspar I; Chappuis PO; Bouchardy C
Int J Cancer; 2008 Mar; 122(5):1114-7. PubMed ID: 17973260
[TBL] [Abstract][Full Text] [Related]
2. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer risk factors and second primary malignancies among women with breast cancer.
Trentham-Dietz A; Newcomb PA; Nichols HB; Hampton JM
Breast Cancer Res Treat; 2007 Oct; 105(2):195-207. PubMed ID: 17186360
[TBL] [Abstract][Full Text] [Related]
4. The impact of in situ breast cancer and family history on risk of subsequent breast cancer events and mortality - a population-based study from Sweden.
Sackey H; Hui M; Czene K; Verkooijen H; Edgren G; Frisell J; Hartman M
Breast Cancer Res; 2016 Oct; 18(1):105. PubMed ID: 27756431
[TBL] [Abstract][Full Text] [Related]
5. Risk of new primary nonbreast cancers after breast cancer treatment: a Dutch population-based study.
Schaapveld M; Visser O; Louwman MJ; de Vries EG; Willemse PH; Otter R; van der Graaf WT; Coebergh JW; van Leeuwen FE
J Clin Oncol; 2008 Mar; 26(8):1239-46. PubMed ID: 18323547
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer prognosis in relation to family history of breast and ovarian cancer.
Thalib L; Wedrén S; Granath F; Adami HO; Rydh B; Magnusson C; Hall P
Br J Cancer; 2004 Apr; 90(7):1378-81. PubMed ID: 15054458
[TBL] [Abstract][Full Text] [Related]
7. Epithelial ovarian cancer and low malignant potential (LMP) tumors associated with a lower incidence of second primary breast cancer.
Hunter MI; Ziogas A; Flores F; Brewster WR
Am J Clin Oncol; 2007 Feb; 30(1):1-7. PubMed ID: 17278887
[TBL] [Abstract][Full Text] [Related]
8. Risk of second breast cancer according to estrogen receptor status and family history.
Bouchardy C; Benhamou S; Fioretta G; Verkooijen HM; Chappuis PO; Neyroud-Caspar I; Castiglione M; Vinh-Hung V; Vlastos G; Rapiti E
Breast Cancer Res Treat; 2011 May; 127(1):233-41. PubMed ID: 20878464
[TBL] [Abstract][Full Text] [Related]
9. Risk of ovarian cancer in breast-cancer patients with a family history of breast or ovarian cancer: a population-based cohort study.
Bergfeldt K; Rydh B; Granath F; Grönberg H; Thalib L; Adami HO; Hall P
Lancet; 2002 Sep; 360(9337):891-4. PubMed ID: 12354469
[TBL] [Abstract][Full Text] [Related]
10. Increased risk of second cancer among patients with ovarian borderline tumors.
Bouchardy C; Fernandez S; Merglen A; Usel M; Fioretta G; Rapiti E; Schubert H; Pelte MF; Chappuis PO; Vlastos G
Gynecol Oncol; 2008 May; 109(2):210-4. PubMed ID: 18377966
[TBL] [Abstract][Full Text] [Related]
11. Risk of a second malignant neoplasm among 5-year survivors of cancer in childhood and adolescence in British Columbia, Canada.
MacArthur AC; Spinelli JJ; Rogers PC; Goddard KJ; Phillips N; McBride ML
Pediatr Blood Cancer; 2007 Apr; 48(4):453-9. PubMed ID: 16767718
[TBL] [Abstract][Full Text] [Related]
12. Risk of second malignant neoplasms after childhood leukemia and lymphoma: an international study.
Maule M; Scélo G; Pastore G; Brennan P; Hemminki K; Tracey E; Sankila R; Weiderpass E; Olsen JH; McBride ML; Brewster DH; Pompe-Kirn V; Kliewer EV; Chia KS; Tonita JM; Martos C; Jonasson JG; Merletti F; Boffetta P
J Natl Cancer Inst; 2007 May; 99(10):790-800. PubMed ID: 17505074
[TBL] [Abstract][Full Text] [Related]
13. Second neoplasms after invasive and borderline ovarian cancer.
Levi F; Randimbison L; Blanc-Moya R; La Vecchia C
Eur J Cancer Prev; 2009 Jun; 18(3):216-9. PubMed ID: 19491608
[TBL] [Abstract][Full Text] [Related]
14. Risk of second primary cancer among women with breast cancer: a population-based study in Granada (Spain).
Molina-Montes E; Pollán M; Payer T; Molina E; Dávila-Arias C; Sánchez MJ
Gynecol Oncol; 2013 Aug; 130(2):340-5. PubMed ID: 23648471
[TBL] [Abstract][Full Text] [Related]
15. The impact of family history on ovarian cancer risk. The Utah Population Database.
Kerber RA; Slattery ML
Arch Intern Med; 1995 May; 155(9):905-12. PubMed ID: 7726698
[TBL] [Abstract][Full Text] [Related]
16. Set-up of a population-based familial breast cancer registry in Geneva, Switzerland: validation of first results.
Verkooijen HM; Fioretta G; Chappuis PO; Vlastos G; Sappino AP; Benhamou S; Bouchardy C
Ann Oncol; 2004 Feb; 15(2):350-3. PubMed ID: 14760133
[TBL] [Abstract][Full Text] [Related]
17. Risk of second primary cancer among patients with early operable breast cancer registered or randomised in Danish Breast Cancer cooperative Group (DBCG) protocols of the 77, 82 and 89 programmes during 1977-2001.
Andersson M; Jensen MB; Engholm G; Henrik Storm H
Acta Oncol; 2008; 47(4):755-64. PubMed ID: 18465345
[TBL] [Abstract][Full Text] [Related]
18. Other Primary Malignancies Among Women With Adult-Type Ovarian Granulosa Cell Tumors.
Bryk S; Pukkala E; Färkkilä A; Heikinheimo M; Unkila-Kallio L; Riska A
Int J Gynecol Cancer; 2018 Oct; 28(8):1529-1534. PubMed ID: 30036228
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
20. Cancer risk in close relatives of women with early-onset breast cancer--a population-based incidence study.
Olsen JH; Seersholm N; Boice JD; Krüger Kjaer S; Fraumeni JF
Br J Cancer; 1999 Feb; 79(3-4):673-9. PubMed ID: 10027348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
